153 related articles for article (PubMed ID: 20837363)
1. Tau haplotypes and ApoE4 do not act in synergy on Alzheimer's disease.
Almos PZ; Horváth S; Czibula A; Raskó I; Domján N; Juhász A; Janka Z; Kálmán J
Psychiatry Res; 2011 Apr; 186(2-3):448-50. PubMed ID: 20837363
[TBL] [Abstract][Full Text] [Related]
2. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
Hong GS; Heun R; Jessen F; Popp J; Hentschel F; Kelemen P; Schulz A; Maier W; Kölsch H
Neurobiol Aging; 2009 May; 30(5):691-6. PubMed ID: 17904251
[TBL] [Abstract][Full Text] [Related]
3. The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia.
Samaranch L; Cervantes S; Barabash A; Alonso A; Cabranes JA; Lamet I; Ancín I; Lorenzo E; Martínez-Lage P; Marcos A; Clarimón J; Alcolea D; Lleó A; Blesa R; Gómez-Isla T; Pastor P
J Alzheimers Dis; 2010; 22(4):1065-71. PubMed ID: 20930301
[TBL] [Abstract][Full Text] [Related]
4. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
[TBL] [Abstract][Full Text] [Related]
5. Presenilin 1 polymorphism associated with Alzheimer's disease in apolipoprotein E4 carriers.
Martínez-García A; Aldudo J; Recuero M; Sastre I; Vilella-Cuadrada E; Rosich-Estragó M; Frank A; Valdivieso F; Bullido MJ
Dement Geriatr Cogn Disord; 2008; 26(5):440-4. PubMed ID: 18957849
[TBL] [Abstract][Full Text] [Related]
6. The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a chinese population.
Tsai SJ; Hong CJ; Liu HC; Liu TY; Liou YJ
Dement Geriatr Cogn Disord; 2006; 21(3):139-43. PubMed ID: 16391475
[TBL] [Abstract][Full Text] [Related]
7. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
[TBL] [Abstract][Full Text] [Related]
8. -1154G/A and -2578C/A polymorphisms of the vascular endothelial growth factor gene in Tunisian Alzheimer patients in relation to beta-amyloid (1-42) and total tau protein.
Smach MA; Charfeddine B; Othman LB; Lammouchi T; Ltaief A; Nafati S; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2010 Mar; 472(2):139-42. PubMed ID: 20138124
[TBL] [Abstract][Full Text] [Related]
9. Molecular evolution and genetics of the Saitohin gene and tau haplotype in Alzheimer's disease and argyrophilic grain disease.
Conrad C; Vianna C; Schultz C; Thal DR; Ghebremedhin E; Lenz J; Braak H; Davies P
J Neurochem; 2004 Apr; 89(1):179-88. PubMed ID: 15030402
[TBL] [Abstract][Full Text] [Related]
10. Analysis of UBQLN1 variants in a Polish Alzheimer's disease patient: control series.
Golan MP; Melquist S; Safranow K; Styczyńska M; Słowik A; Kobryś M; Zekanowski C; Barcikowska M
Dement Geriatr Cogn Disord; 2008; 25(4):366-71. PubMed ID: 18340109
[TBL] [Abstract][Full Text] [Related]
11. Association study of the GAB2 gene with the risk of developing Alzheimer's disease.
Chapuis J; Hannequin D; Pasquier F; Bentham P; Brice A; Leber I; Frebourg T; Deleuze JF; Cousin E; Thaker U; Amouyel P; Mann D; Lendon C; Campion D; Lambert JC
Neurobiol Dis; 2008 Apr; 30(1):103-6. PubMed ID: 18272374
[TBL] [Abstract][Full Text] [Related]
12. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
13. Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease.
Laws SM; Friedrich P; Diehl-Schmid J; Müller J; Eisele T; Bäuml J; Förstl H; Kurz A; Riemenschneider M
Mol Psychiatry; 2007 May; 12(5):510-7. PubMed ID: 17179995
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease.
Wang B; Zhou S; Yang Z; Xie YC; Wang J; Zhang P; Lv Z; Zheng C; Ma X
J Neurol Sci; 2008 Jul; 270(1-2):148-51. PubMed ID: 18396294
[TBL] [Abstract][Full Text] [Related]
15. The extended tau haplotype and the age of onset of dementia in Down syndrome.
Jones EL; Margallo-Lana M; Prasher VP; Ballard CG
Dement Geriatr Cogn Disord; 2008; 26(3):199-202. PubMed ID: 18765933
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease.
Darreh-Shori T; Siawesh M; Mousavi M; Andreasen N; Nordberg A
J Alzheimers Dis; 2012; 28(2):443-58. PubMed ID: 22012848
[TBL] [Abstract][Full Text] [Related]
17. MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies.
Colom-Cadena M; Gelpi E; Martí MJ; Charif S; Dols-Icardo O; Blesa R; Clarimón J; Lleó A
Neurobiol Aging; 2013 Mar; 34(3):936-42. PubMed ID: 22819391
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
[TBL] [Abstract][Full Text] [Related]
19. 14-3-3 zeta and tau genes interactively decrease Alzheimer's disease risk.
Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Infante J; Fernández-Viadero C; Peña N; Berciano J; Combarros O
Dement Geriatr Cogn Disord; 2008; 25(4):317-20. PubMed ID: 18319590
[TBL] [Abstract][Full Text] [Related]
20. APOE is associated with age-of-onset, but not cognitive functioning, in late-life depression.
Butters MA; Sweet RA; Mulsant BH; Ilyas Kamboh M; Pollock BG; Begley AE; Reynolds CF; DeKosky ST
Int J Geriatr Psychiatry; 2003 Dec; 18(12):1075-81. PubMed ID: 14677138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
